Pages that link to "Q41157204"
Jump to navigation
Jump to search
The following pages link to Loop Diuretics for Chronic Renal Insufficiency: A Continuous Infusion Is More Efficacious Than Bolus Therapy (Q41157204):
Displaying 50 items.
- Continuous infusion versus bolus injection of loop diuretics in congestive heart failure (Q24246648) (← links)
- Continuous infusion versus bolus injection of loop diuretics in congestive heart failure (Q24247392) (← links)
- Current and Potential Therapeutic Strategies for Hemodynamic Cardiorenal Syndrome (Q26753862) (← links)
- Loop Diuretics in Clinical Practice (Q26799308) (← links)
- Effects of applying a standardised management algorithm for moderate to severe renal dysfunction in patients with chronic stable heart failure (Q28212766) (← links)
- Discrepancy between bioavailability as estimated from urinary recovery of frusemide and total diuretic effect (Q28768395) (← links)
- Diuretic treatment and diuretic resistance in heart failure (Q33631125) (← links)
- Clinical consequences of the biphasic elimination kinetics for the diuretic effect of furosemide and its acyl glucuronide in humans (Q33645430) (← links)
- The efficiency concept in pharmacodynamics. (Q33672006) (← links)
- An evaluation of pharmacological strategies for the prevention and treatment of acute renal failure (Q33863403) (← links)
- The use of diuretics and dopamine in acute renal failure: a systematic review of the evidence (Q34091459) (← links)
- Oliguria in the ICU. Systematic approach to diagnosis and treatment (Q34091607) (← links)
- Fluid and electrolyte abnormalities (Q34348041) (← links)
- Pharmacotherapy in congestive heart failure: diuretic resistance and strategies to overcome resistance in patients with congestive heart failure (Q34584204) (← links)
- Balancing diuretic therapy in heart failure: loop diuretics, thiazides, and aldosterone antagonists (Q35013821) (← links)
- Loop diuretics: from the Na-K-2Cl transporter to clinical use. (Q35021347) (← links)
- Randomized, open-label, blinded-endpoint, crossover, single-dose study to compare the pharmacodynamics of torasemide-PR 10 mg, torasemide-IR 10 mg, and furosemide-IR 40 mg, in patients with chronic heart failure (Q35940064) (← links)
- Diuretic strategies in patients with acute decompensated heart failure (Q36141962) (← links)
- Heart failure: furosemide--to DOSE or not to DOSE, that is the question (Q36148695) (← links)
- Management of refractory congestive heart failure (Q36303919) (← links)
- Rapid and Highly Accurate Prediction of Poor Loop Diuretic Natriuretic Response in Patients With Heart Failure (Q36543885) (← links)
- Efficacy and safety of a furosemide continuous infusion following cardiac surgery (Q36586122) (← links)
- Diuretic initiation and the acute risk of hip fracture (Q36676154) (← links)
- Loop diuretics in acute decompensated heart failure: necessary? Evil? A necessary evil? (Q37343008) (← links)
- Management of loop diuretic resistance in the intensive care unit (Q37591692) (← links)
- Diuretics in heart failure: a critical appraisal of efficacy and tolerability (Q37632385) (← links)
- Metabolic and toxicological considerations for diuretic therapy in patients with acute heart failure. (Q37877721) (← links)
- Diuretic use in renal disease (Q37969997) (← links)
- Efficacy and safety of loop diuretic therapy in acute decompensated heart failure: a clinical review (Q38058411) (← links)
- Causes and treatment of oedema in patients with heart failure (Q38074093) (← links)
- Pharmacologic strategies to preserve renal function in acute decompensated heart failure (Q38270564) (← links)
- Continuous infusion of furosemide in the treatment of patients with congestive heart failure and diuretic resistance (Q39485460) (← links)
- Diuretic strategies in patients with renal failure (Q40395468) (← links)
- Clinical problems of diuretic treatment (Q40588272) (← links)
- Influence of drug formulation on drug concentration-effect relationships (Q40743022) (← links)
- Diuretic drugs and the treatment of edema: from clinic to bench and back again (Q40747326) (← links)
- The role of continuous infusion loop diuretics (Q41142594) (← links)
- Diuretic combinations in refractory oedema states: pharmacokinetic-pharmacodynamic relationships (Q41177651) (← links)
- Drug therapy for congestive heart failure. Appropriate choices can prolong life (Q41329602) (← links)
- Edema and principles of diuretic use. (Q41484985) (← links)
- Combination diuretic therapy in severe congestive heart failure. (Q41722655) (← links)
- Goal-directed diuresis: A case - control study of continuous furosemide infusion in critically ill trauma patients (Q42030690) (← links)
- A study of the pharmacodynamic differences between immediate and extended release bumetanide formulations (Q44645317) (← links)
- Modern differential therapy with diuretics (Q44888613) (← links)
- Mechanisms and management of nephrotic edema (Q46192208) (← links)
- The comparison of the diuretic and natriuretic efficacy of continuous and bolus intravenous furosemide in patients with chronic kidney disease (Q46721899) (← links)
- Comparison of bumetanide- and metolazone-based diuretic regimens to furosemide in acute heart failure (Q46881476) (← links)
- Renal function monitoring in heart failure - what is the optimal frequency? A narrative review (Q47140028) (← links)
- Sodium and Fluid Excretion With Torsemide in Healthy Subjects is Limited by the Short Duration of Diuretic Action (Q47148000) (← links)
- Comparison of metolazone versus chlorothiazide in acute decompensated heart failure with diuretic resistance. (Q51005006) (← links)